Choose a trusted technology
Choose the best InterStim™ system for each patient. Both systems are full-body* MRI eligible and deliver the same therapy with long-term relief.1-3
InterStim™ II system
The previous generation recharge-free device.Product Details
The most common adverse events experienced during clinical studies include pain at implant sites, new pain, lead migration, infection, technical or device problems, adverse change in bowel or voiding function, and undesirable stimulation or sensations. Any of these may require additional surgery or cause return of symptoms.
Siegel S, Noblett K, Mangel J, et al. Five-year follow-up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. The Journal of Urology 2018, 229–236.
Medtronic InterStim Therapy Clinical Summary (2018).
Hull T, Giese C, Wexner SD, et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56(2):23.
Under certain conditions; see approved labeling for details. Patients with InterStim™ SureScan™ MRI Leads only.